• Brompheniramine
  • Neuron-Specific Enolase (NSE), Serum
  • Treponema pallidum Antibody, FTA-ABS, IgG, CSF
  • Lipoprotein Associated Phospholipase A2 Activity
  • Cirrhosis of the Liver
  • X-Inactivation (XIST), Xq13.2 Deletion
  • CD8 Lymphocyte Count
  • Cytomegalovirus (CMV) Genotyping and Drug Resistance
  • Boron, Quantitative, Serum
  • Vancomycin, Peak, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /ROMA Score for Ovarian Cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • Panel Test Components
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • Panel Test Components

ROMA Score for Ovarian Cancer Risk Assessment
Medical Test

Clinical Utility
Access to ROMA Score for Ovarian Cancer Risk Assessment is restricted.